Skip to main content
. 2021 Apr 1;12(10):1570–1578. doi: 10.1111/1759-7714.13945

TABLE 1.

Patient characteristics (n = 111)

Characteristics n (%)
Age, years
Median age (range) 62 (39–75)
<60 42 (37.8)
≥60 69 (62.2)
Sex
Male 69 (62.2)
Female 42 (37.8)
Smoking status
Never smoker 39 (35.1)
Smoker 72 (64.9)
Histological type
AD 81 (73.0)
Non‐AD 30 (27.0)
p‐TNM stage
Stage II 35 (31.5)
Stage IIIA 76 (68.5)
Chemotherapeutic regimen
CBDCA based 28 (25.2)
CDDP based 83 (74.8)
Number of treatment cycle
1–2 15 (13.5)
3–4 96 (86.5)
Survival status
Alive 60 (54.1)
Lung cancer‐related death 40 (36.0)
Other causes of death 5 (4.5)
Unknown 6 (5.4)

Abbreviations: AD, adenocarcinoma; CBDCA, carboplatin; CDDP, cisplatin; p‐TNM, pathological TNM eighth edition.